novell pharmaceutical laboratories
 Search
Home | Contact Us    
our product
 
  Metabolism
Other Agents Affecting Metabolism
 
BONEVELL

Indications

- Treatment of metastatic bone disease, to reduce the risk of skeletal complications of malignant disease including hypercalcemia, pain, the need for radiotherapy against painful bone lesions and impending fractures, and decrease the risk for fractures
- Treatment of tumor-induced hypercalcemia


Pharmacology

Each 6 mL of Bonevell contains

Ibandronate Sodium 6.75 mg equivalent with Ibandronic Acid 6 mg


Package Quantities

Box 1 vial @ 6 ml


 
Ostovel

Indications

Postmenopausal osteoporosis, Renal osteodystrophy in patients with chronic renal failure, postsurgical hypoparathyroidism, idiophatic hypoparathyroidism, pseudohypoparathyodism, Vitamin D-dependency rickets


Pharmacology

Each OSTOVEL softgel contains:
Calcitriol ….………….……0.25 mg


Package Quantities

Bottle @ 30 softgels


 
Zolenic

Indications

Prevention of skeletal related events (pathological fractures, spinal compression, radiation or surgery to bone, or tumour-induced hypercalcaemia) in patients with advanced maglinancies involving bone.
Treatment of Hypercalcaemia of Malignancy  (HCM) "


Pharmacology

Each Zolenic contains Zoledronic Acid 4 mg


Package Quantities

Box of 5ml vial


 
     
Copyright © 2018 - Novell Pharmaceutical Labs. All right reserved